Development of a Hypertension Electronic Phenotype for Chronic Disease Surveillance in Electronic Health Records: Key Analytic Decisions and Their Effects
IntroductionModernizing chronic disease surveillance with electronic health record (EHR) data may provide better data to improve hypertension prevention and control, but no consensus exists for an EHR-based surveillance definition for hypertension. The Multi-State EHR-Based Network for Disease Surve...
Gespeichert in:
Veröffentlicht in: | Preventing chronic disease 2023-09, Vol.20, p.E80, Article 230026 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | E80 |
container_title | Preventing chronic disease |
container_volume | 20 |
creator | Hohman, Katherine H. Zambarano, Bob Klompas, Michael Wall, Hilary K. Kraus, Emily M. Carton, Thomas W. Jackson, Sandra L. |
description | IntroductionModernizing chronic disease surveillance with electronic health record (EHR) data may provide better data to improve hypertension prevention and control, but no consensus exists for an EHR-based surveillance definition for hypertension. The Multi-State EHR-Based Network for Disease Surveillance (MENDS) pilot surveillance system was used to develop and test an electronic phenotype for hypertension.MethodsWe used MENDS data from 1,671,544 patients in Louisiana to examine the effect of different analytic decisions on estimates of hypertension prevalence. Decisions included 1) whether to restrict surveillance to patients with recent blood pressure measurements, 2) varying the number and recency of encounters to define the population at risk of hypertension, 3) how to define hypertension (diagnosis codes, antihypertensive medication, blood pressure measurements, or combinations of these), and 4) how to handle multiple blood pressure measurements on the same day. Results were compared with independent estimates of hypertension prevalence in Louisiana from the Behavioral Risk Factor Surveillance System (BRFSS).ResultsApplying varying criteria resulted in hypertension prevalence estimates ranging from 19.7% to 59.3%. A hypertension surveillance strategy that includes a population with at least 1 clinical encounter with measured blood pressure in the previous 2 years and identifies hypertension using all available data (≥1 diagnosis code, ≥1 antihypertensive medication, and ≥2 elevated blood pressure values ≥140/90 mm Hg on separate days) generated estimates in line with population-based survey data. This definition estimated the crude 2019 hypertension prevalence in the state of Louisiana as 43.4% (age-adjusted, 41.0%), comparable with the crude BRFSS estimate of 39.7% (age adjusted, 37.1%).ConclusionApplying different criteria to define hypertension using EHR data has a large effect on hypertension prevalence estimates. The proposed electronic phenotype generates hypertension prevalence estimates that align with independent estimates from BRFSS.SummaryWhat is already known on this topic?Previous studies have identified hypertension from electronic health records (EHRs), but the effects of analytic decisions on prevalence estimates have not been characterized, and a consensus definition has not been established.What is added by this report?This report addresses a gap in the literature by providing results and analytic interpretations related to differe |
doi_str_mv | 10.5888/pcd20.230026 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10516201</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3116482716</sourcerecordid><originalsourceid>FETCH-LOGICAL-c390t-780334c24da7a45409c77f3496c7884bbc2c56f45e4f235d10ec452f717e19f73</originalsourceid><addsrcrecordid>eNpdUU1v1DAQtRCIlsKNH2CJCwe2-DN2uKBqu3RRKxVBOVteZ0xcZe3UTlbav8KvbdKtEO1pRjPvvRm9h9B7Sk6l1vpz7xpGThknhFUv0DGVQi4olfTlf_0RelPK7YRQRFWv0RFXimjO62P09xx20KV-C3HAyWOL1_se8gCxhBTxqgM35BSDwz9aiGmYltinjJftYXoeCtgC-NeYdxC6zkYHODwhrsF2Q4t_gku5KV_wJezxWbTdfpj54MJ8qWAbG3zTQsh45f1ELm_RK2-7Au8e6wn6_W11s1wvrq4vvi_PrhaO12RYKE04F46JxiorpCC1U8pzUVdOaS02G8ecrLyQIDzjsqEEnJDMK6qA1l7xE_T1oNuPmy00bnIi2870OWxt3ptkg3m6iaE1f9LOUCJpxQidFD4-KuR0N0IZzDYUB7MbkMZimK7k9ItS87EPz6C3acyTG8VwSiuhmaLVhPp0QLmcSsng_31DiZlTNw-pm0Pq_B4ITaBz</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3116482716</pqid></control><display><type>article</type><title>Development of a Hypertension Electronic Phenotype for Chronic Disease Surveillance in Electronic Health Records: Key Analytic Decisions and Their Effects</title><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Hohman, Katherine H. ; Zambarano, Bob ; Klompas, Michael ; Wall, Hilary K. ; Kraus, Emily M. ; Carton, Thomas W. ; Jackson, Sandra L.</creator><creatorcontrib>Hohman, Katherine H. ; Zambarano, Bob ; Klompas, Michael ; Wall, Hilary K. ; Kraus, Emily M. ; Carton, Thomas W. ; Jackson, Sandra L.</creatorcontrib><description>IntroductionModernizing chronic disease surveillance with electronic health record (EHR) data may provide better data to improve hypertension prevention and control, but no consensus exists for an EHR-based surveillance definition for hypertension. The Multi-State EHR-Based Network for Disease Surveillance (MENDS) pilot surveillance system was used to develop and test an electronic phenotype for hypertension.MethodsWe used MENDS data from 1,671,544 patients in Louisiana to examine the effect of different analytic decisions on estimates of hypertension prevalence. Decisions included 1) whether to restrict surveillance to patients with recent blood pressure measurements, 2) varying the number and recency of encounters to define the population at risk of hypertension, 3) how to define hypertension (diagnosis codes, antihypertensive medication, blood pressure measurements, or combinations of these), and 4) how to handle multiple blood pressure measurements on the same day. Results were compared with independent estimates of hypertension prevalence in Louisiana from the Behavioral Risk Factor Surveillance System (BRFSS).ResultsApplying varying criteria resulted in hypertension prevalence estimates ranging from 19.7% to 59.3%. A hypertension surveillance strategy that includes a population with at least 1 clinical encounter with measured blood pressure in the previous 2 years and identifies hypertension using all available data (≥1 diagnosis code, ≥1 antihypertensive medication, and ≥2 elevated blood pressure values ≥140/90 mm Hg on separate days) generated estimates in line with population-based survey data. This definition estimated the crude 2019 hypertension prevalence in the state of Louisiana as 43.4% (age-adjusted, 41.0%), comparable with the crude BRFSS estimate of 39.7% (age adjusted, 37.1%).ConclusionApplying different criteria to define hypertension using EHR data has a large effect on hypertension prevalence estimates. The proposed electronic phenotype generates hypertension prevalence estimates that align with independent estimates from BRFSS.SummaryWhat is already known on this topic?Previous studies have identified hypertension from electronic health records (EHRs), but the effects of analytic decisions on prevalence estimates have not been characterized, and a consensus definition has not been established.What is added by this report?This report addresses a gap in the literature by providing results and analytic interpretations related to different decision points in the EHR-based electronic phenotype development process and proposes an optimal definition for EHR-based hypertension.What are the implications for public health practice?Analytic decisions have a large effect on EHR-based estimates of hypertension prevalence. Parties working to advance chronic disease data modernization using EHR data can apply this EHR-based definition for surveillance of hypertension prevalence and control.</description><identifier>ISSN: 1545-1151</identifier><identifier>EISSN: 1545-1151</identifier><identifier>DOI: 10.5888/pcd20.230026</identifier><identifier>PMID: 37708339</identifier><language>eng</language><publisher>Atlanta: Centers for Disease Control and Prevention</publisher><subject>Chronic illnesses ; Clinical decision making ; Electronic health records ; Generic drugs ; Health surveillance ; Hypertension ; Original Research ; Pharmacists</subject><ispartof>Preventing chronic disease, 2023-09, Vol.20, p.E80, Article 230026</ispartof><rights>Published 2023. This article is a U.S. Government work and is in the public domain in the USA.</rights><rights>2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c390t-780334c24da7a45409c77f3496c7884bbc2c56f45e4f235d10ec452f717e19f73</citedby><cites>FETCH-LOGICAL-c390t-780334c24da7a45409c77f3496c7884bbc2c56f45e4f235d10ec452f717e19f73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10516201/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10516201/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids></links><search><creatorcontrib>Hohman, Katherine H.</creatorcontrib><creatorcontrib>Zambarano, Bob</creatorcontrib><creatorcontrib>Klompas, Michael</creatorcontrib><creatorcontrib>Wall, Hilary K.</creatorcontrib><creatorcontrib>Kraus, Emily M.</creatorcontrib><creatorcontrib>Carton, Thomas W.</creatorcontrib><creatorcontrib>Jackson, Sandra L.</creatorcontrib><title>Development of a Hypertension Electronic Phenotype for Chronic Disease Surveillance in Electronic Health Records: Key Analytic Decisions and Their Effects</title><title>Preventing chronic disease</title><description>IntroductionModernizing chronic disease surveillance with electronic health record (EHR) data may provide better data to improve hypertension prevention and control, but no consensus exists for an EHR-based surveillance definition for hypertension. The Multi-State EHR-Based Network for Disease Surveillance (MENDS) pilot surveillance system was used to develop and test an electronic phenotype for hypertension.MethodsWe used MENDS data from 1,671,544 patients in Louisiana to examine the effect of different analytic decisions on estimates of hypertension prevalence. Decisions included 1) whether to restrict surveillance to patients with recent blood pressure measurements, 2) varying the number and recency of encounters to define the population at risk of hypertension, 3) how to define hypertension (diagnosis codes, antihypertensive medication, blood pressure measurements, or combinations of these), and 4) how to handle multiple blood pressure measurements on the same day. Results were compared with independent estimates of hypertension prevalence in Louisiana from the Behavioral Risk Factor Surveillance System (BRFSS).ResultsApplying varying criteria resulted in hypertension prevalence estimates ranging from 19.7% to 59.3%. A hypertension surveillance strategy that includes a population with at least 1 clinical encounter with measured blood pressure in the previous 2 years and identifies hypertension using all available data (≥1 diagnosis code, ≥1 antihypertensive medication, and ≥2 elevated blood pressure values ≥140/90 mm Hg on separate days) generated estimates in line with population-based survey data. This definition estimated the crude 2019 hypertension prevalence in the state of Louisiana as 43.4% (age-adjusted, 41.0%), comparable with the crude BRFSS estimate of 39.7% (age adjusted, 37.1%).ConclusionApplying different criteria to define hypertension using EHR data has a large effect on hypertension prevalence estimates. The proposed electronic phenotype generates hypertension prevalence estimates that align with independent estimates from BRFSS.SummaryWhat is already known on this topic?Previous studies have identified hypertension from electronic health records (EHRs), but the effects of analytic decisions on prevalence estimates have not been characterized, and a consensus definition has not been established.What is added by this report?This report addresses a gap in the literature by providing results and analytic interpretations related to different decision points in the EHR-based electronic phenotype development process and proposes an optimal definition for EHR-based hypertension.What are the implications for public health practice?Analytic decisions have a large effect on EHR-based estimates of hypertension prevalence. Parties working to advance chronic disease data modernization using EHR data can apply this EHR-based definition for surveillance of hypertension prevalence and control.</description><subject>Chronic illnesses</subject><subject>Clinical decision making</subject><subject>Electronic health records</subject><subject>Generic drugs</subject><subject>Health surveillance</subject><subject>Hypertension</subject><subject>Original Research</subject><subject>Pharmacists</subject><issn>1545-1151</issn><issn>1545-1151</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNpdUU1v1DAQtRCIlsKNH2CJCwe2-DN2uKBqu3RRKxVBOVteZ0xcZe3UTlbav8KvbdKtEO1pRjPvvRm9h9B7Sk6l1vpz7xpGThknhFUv0DGVQi4olfTlf_0RelPK7YRQRFWv0RFXimjO62P09xx20KV-C3HAyWOL1_se8gCxhBTxqgM35BSDwz9aiGmYltinjJftYXoeCtgC-NeYdxC6zkYHODwhrsF2Q4t_gku5KV_wJezxWbTdfpj54MJ8qWAbG3zTQsh45f1ELm_RK2-7Au8e6wn6_W11s1wvrq4vvi_PrhaO12RYKE04F46JxiorpCC1U8pzUVdOaS02G8ecrLyQIDzjsqEEnJDMK6qA1l7xE_T1oNuPmy00bnIi2870OWxt3ptkg3m6iaE1f9LOUCJpxQidFD4-KuR0N0IZzDYUB7MbkMZimK7k9ItS87EPz6C3acyTG8VwSiuhmaLVhPp0QLmcSsng_31DiZlTNw-pm0Pq_B4ITaBz</recordid><startdate>20230914</startdate><enddate>20230914</enddate><creator>Hohman, Katherine H.</creator><creator>Zambarano, Bob</creator><creator>Klompas, Michael</creator><creator>Wall, Hilary K.</creator><creator>Kraus, Emily M.</creator><creator>Carton, Thomas W.</creator><creator>Jackson, Sandra L.</creator><general>Centers for Disease Control and Prevention</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20230914</creationdate><title>Development of a Hypertension Electronic Phenotype for Chronic Disease Surveillance in Electronic Health Records: Key Analytic Decisions and Their Effects</title><author>Hohman, Katherine H. ; Zambarano, Bob ; Klompas, Michael ; Wall, Hilary K. ; Kraus, Emily M. ; Carton, Thomas W. ; Jackson, Sandra L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c390t-780334c24da7a45409c77f3496c7884bbc2c56f45e4f235d10ec452f717e19f73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Chronic illnesses</topic><topic>Clinical decision making</topic><topic>Electronic health records</topic><topic>Generic drugs</topic><topic>Health surveillance</topic><topic>Hypertension</topic><topic>Original Research</topic><topic>Pharmacists</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hohman, Katherine H.</creatorcontrib><creatorcontrib>Zambarano, Bob</creatorcontrib><creatorcontrib>Klompas, Michael</creatorcontrib><creatorcontrib>Wall, Hilary K.</creatorcontrib><creatorcontrib>Kraus, Emily M.</creatorcontrib><creatorcontrib>Carton, Thomas W.</creatorcontrib><creatorcontrib>Jackson, Sandra L.</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Preventing chronic disease</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hohman, Katherine H.</au><au>Zambarano, Bob</au><au>Klompas, Michael</au><au>Wall, Hilary K.</au><au>Kraus, Emily M.</au><au>Carton, Thomas W.</au><au>Jackson, Sandra L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Development of a Hypertension Electronic Phenotype for Chronic Disease Surveillance in Electronic Health Records: Key Analytic Decisions and Their Effects</atitle><jtitle>Preventing chronic disease</jtitle><date>2023-09-14</date><risdate>2023</risdate><volume>20</volume><spage>E80</spage><pages>E80-</pages><artnum>230026</artnum><issn>1545-1151</issn><eissn>1545-1151</eissn><abstract>IntroductionModernizing chronic disease surveillance with electronic health record (EHR) data may provide better data to improve hypertension prevention and control, but no consensus exists for an EHR-based surveillance definition for hypertension. The Multi-State EHR-Based Network for Disease Surveillance (MENDS) pilot surveillance system was used to develop and test an electronic phenotype for hypertension.MethodsWe used MENDS data from 1,671,544 patients in Louisiana to examine the effect of different analytic decisions on estimates of hypertension prevalence. Decisions included 1) whether to restrict surveillance to patients with recent blood pressure measurements, 2) varying the number and recency of encounters to define the population at risk of hypertension, 3) how to define hypertension (diagnosis codes, antihypertensive medication, blood pressure measurements, or combinations of these), and 4) how to handle multiple blood pressure measurements on the same day. Results were compared with independent estimates of hypertension prevalence in Louisiana from the Behavioral Risk Factor Surveillance System (BRFSS).ResultsApplying varying criteria resulted in hypertension prevalence estimates ranging from 19.7% to 59.3%. A hypertension surveillance strategy that includes a population with at least 1 clinical encounter with measured blood pressure in the previous 2 years and identifies hypertension using all available data (≥1 diagnosis code, ≥1 antihypertensive medication, and ≥2 elevated blood pressure values ≥140/90 mm Hg on separate days) generated estimates in line with population-based survey data. This definition estimated the crude 2019 hypertension prevalence in the state of Louisiana as 43.4% (age-adjusted, 41.0%), comparable with the crude BRFSS estimate of 39.7% (age adjusted, 37.1%).ConclusionApplying different criteria to define hypertension using EHR data has a large effect on hypertension prevalence estimates. The proposed electronic phenotype generates hypertension prevalence estimates that align with independent estimates from BRFSS.SummaryWhat is already known on this topic?Previous studies have identified hypertension from electronic health records (EHRs), but the effects of analytic decisions on prevalence estimates have not been characterized, and a consensus definition has not been established.What is added by this report?This report addresses a gap in the literature by providing results and analytic interpretations related to different decision points in the EHR-based electronic phenotype development process and proposes an optimal definition for EHR-based hypertension.What are the implications for public health practice?Analytic decisions have a large effect on EHR-based estimates of hypertension prevalence. Parties working to advance chronic disease data modernization using EHR data can apply this EHR-based definition for surveillance of hypertension prevalence and control.</abstract><cop>Atlanta</cop><pub>Centers for Disease Control and Prevention</pub><pmid>37708339</pmid><doi>10.5888/pcd20.230026</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1545-1151 |
ispartof | Preventing chronic disease, 2023-09, Vol.20, p.E80, Article 230026 |
issn | 1545-1151 1545-1151 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10516201 |
source | EZB-FREE-00999 freely available EZB journals; PubMed Central; PubMed Central Open Access |
subjects | Chronic illnesses Clinical decision making Electronic health records Generic drugs Health surveillance Hypertension Original Research Pharmacists |
title | Development of a Hypertension Electronic Phenotype for Chronic Disease Surveillance in Electronic Health Records: Key Analytic Decisions and Their Effects |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T13%3A27%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Development%20of%20a%20Hypertension%20Electronic%20Phenotype%20for%20Chronic%20Disease%20Surveillance%20in%20Electronic%20Health%20Records:%20Key%20Analytic%20Decisions%20and%20Their%20Effects&rft.jtitle=Preventing%20chronic%20disease&rft.au=Hohman,%20Katherine%20H.&rft.date=2023-09-14&rft.volume=20&rft.spage=E80&rft.pages=E80-&rft.artnum=230026&rft.issn=1545-1151&rft.eissn=1545-1151&rft_id=info:doi/10.5888/pcd20.230026&rft_dat=%3Cproquest_pubme%3E3116482716%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3116482716&rft_id=info:pmid/37708339&rfr_iscdi=true |